Ayurvedic-Life International, LLC
We are in Phase 2 development of a drug that will delay and/or prevent the onset of Type 2 Diabetes. Seeking capital for Phase 2/3.
Our in vitro research at Battelle Laboratories, the University of Wisconsin at Madison and King's College-London has been fully funded by the company's founders, Arun K. Chatterji, Ph.D. and Dennis E. Torkko. Our multi-patented all natural drug candidate has unique properties that have the potential to delay or prevent the onset of Type 2 Diabetes. Our invention has the power to fundamentally alter the health profile of millions of individuals.